In 2021, there were around *** new cases of breast cancer per 100,000 population in the state of Connecticut, making it the state with the highest breast cancer incidence rate that year. This statistic shows the incidence rate of breast cancer in the U.S. in 2021, by state.

In 2023, there were **** deaths from breast cancer per 100,000 population in the state of South Dakota, the lowest of any state that year. This statistic shows the death rate from breast cancer in the U.S. in 2023, by state.

The U.S. states are divided into groups based on the rates at which women developed or died from breast cancer in 2013, which is the most recent year for which incidence data are available.

Editor’s Choice

• Global Breast Cancer Market size is expected to be worth around USD 49.2 Bn by 2032 from USD 19.8 Bn in 2022, growing at a CAGR of 9.8% during the forecast period from 2022 to 2032.
• Breast cancer is the most common cancer among women worldwide. In 2020, there were about 2.3 million new cases of breast cancer diagnosed globally.
• Breast cancer is the leading cause of cancer-related deaths in women. In 2020, it was responsible for approximately 685,000 deaths worldwide.
• The survival rate of breast cancer has improved over the years. In the United States, the overall five-year survival rate of breast cancer is around 90%.
• The American Cancer Society recommends annual mammograms starting at age 40 for women at average risk.
• Although rare, breast cancer also occurs in men. Less than 1% of breast cancer cases are diagnosed in males.

(Source: WHO, American Cancer Society)

This dataset contains Cancer Incidence data for Breast Cancer (Late Stage^) including: Age-Adjusted Rate, Confidence Interval, Average Annual Count, and Trend field information for US States for the average 5 year span from 2016 to 2020.Data are for females segmented by age (All Ages, Ages Under 50, Ages 50 & Over, Ages Under 65, and Ages 65 & Over), with field names and aliases describing the sex and age group tabulated.For more information, visit statecancerprofiles.cancer.govData NotationsState Cancer Registries may provide more current or more local data.TrendRising when 95% confidence interval of average annual percent change is above 0.Stable when 95% confidence interval of average annual percent change includes 0.Falling when 95% confidence interval of average annual percent change is below 0.† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.‡ Incidence Trend data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information.Rates and trends are computed using different standards for malignancy. For more information see malignant.^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.Data Source Field Key(1) Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.(5) Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.(6) Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).(7) Source: SEER November 2022 submission.(8) Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used with SEER November 2022 data.Some data are not available, see Data Not Available for combinations of geography, cancer site, age, and race/ethnicity.Data for the United States does not include data from Nevada.Data for the United States does not include Puerto Rico.

The dataset consists of the state wise estimated incidence of breast cancer and cervical cancer in India as per the National Cancer Registry Programme. The estimates are computer using age specific incidence Rate of 28 PBCRs of 2012-2016 and the projected population (person-years). NB: Incidence estimates of breast cancer is available since 2016 while that of cervical cancer is available since 2015.

The rate of breast cancer deaths in the U.S. has dramatically declined since 1950. As of 2023, the death rate from breast cancer was **** per 100,000 population. However, cancer is a serious public health issue in the United States and is the second leading cause of death among women. Breast cancer incidence Breast cancer symptoms include lumps or thickening of the breast tissue and may include changes to the skin. Breast cancer is driven by many factors, but age is a known risk factor. Among all age groups, the highest number of invasive breast cancer cases were among those aged 60 to 69. The incidence rate of new breast cancer cases is higher in some ethnicities than others. White, non-Hispanic women have the highest incidence rate of breast cancer, followed by non-Hispanic Black women. Breast cancer treatment Breast cancer treatments usually involve several methods, including surgery, chemotherapy and biological therapy. Types of cancer diagnosed at earlier stages often require fewer treatments. A majority of early stage breast cancer cases in the U.S. receive breast conserving surgery and radiation therapy.

This file contains measured and modeled breast cancer rates by stage and median household income percentile in New York State, 2006-2015. It accompanies the book chapter, "Spatial and Contextual Analyses of Stage at Diagnosis" by Francis Boscoe and Lindsey Hutchison, in Geospatial Approaches to Energy Balance and Breast Cancer. D Berrigan, NA Berger, eds. Berlin: Springer, 2018..4,835 census tracts in New York State were divided into percentiles based on median household income, using data from the 2006-2010 and 2011-2015 editions of American Community Survey Table S1903. Census tracts are defined here:https://figshare.com/articles/Population_Estimates_by_Census_Tract_New_York_State_by_Age_and_Sex_1990-2016_/681302958 of the 4,893 census tracts in this file did not have households (primarily college campuses, prisons, and military bases) and thus had no reported median household income and were excluded, leaving 4,835.200,022 cases of breast cancer diagnosed among New York State residents from 2006-2015 were assigned an income percentile. Cases diagnosed between 2006-2010 were assigned based on the 2006-2010 edition of ACS Table S1903 and cases diagnosed between 2011-2015 were assigned based on the 2011-2015 edition.Directly-adjusted incidence rates were calculated for all cancers and for those diagnosed at in situ, local, regional, and distant stage, using the SEER Summary Stage 2000 staging system. The file contains the following fields: income percentile; rates for all cancers, in situ, local, regional, and distant stage; and modeled rates for all cancers, in situ, local, regional and distant stages. The modeled rates used a polynomial of order 3. The equations of the best-fit lines and r-squared values, to 4 decimal places or significant figures, are as follows:All cancers: y = 0.0001986x3 - 0.02035x2 + 1.0691x + 133.7353, r2 = 0.96In situ: y = 0.00008906x3 - 0.007555x2 + 0.3169x + 27.5728, r2 = 0.96Local: y = 0.0001436x3 - 0.01919x2 + 1.0526x + 58.4627, r2 = 0.94Regional: y = -0.00001676x3 + 0.003410x2 - 0.1389x + 37.6709, r2 = 0.41Distant: y = -0.00001724x3 + 0.002989x2 - 0.1615x + 10.0288, r2 = 0.32

Incidence Rate Of Breast Cancer Per 100,000 All States

One woman in nine can expect to develop breast cancer during her lifetime and one in 25 will die from the disease. Statistically low incidences of breast cancer are found in Newfoundland and Labrador, the territories, and northern areas of most provinces. Otherwise, each province has one or more pockets of significantly high breast cancer incidence. These are often located in more southerly areas, but they do not seem to be restricted to either urban or rural areas alone. Breast cancer rates are a health status indicator. They can be used to help assess health conditions. Health status refers to the state of health of a person or group, and measures causes of sickness and death. It can also include people’s assessment of their own health.

Introduction

Breast Cancer Statistics: Breast cancer remains one of the most prevalent and concerning health challenges, mostly among women. It is the most common cancer diagnosed in women worldwide and the second leading cause of cancer-related deaths among women in the United States. The impact of breast cancer is significant, with millions of new cases diagnosed each year and hundreds of thousands of deaths attributed to the disease.

This article will provide critical insights into the incidence, survival rates, mortality, and disparities across different demographics, including age, race, and ethnicity. Understanding the latest statistics on breast cancer is crucial for driving progress in reducing the incidence and mortality rates, improving survival outcomes, and ultimately, finding a cure.

Breast cancer incidence rates among women in the United States vary by race and ethnicity. Non-Hispanic white women face the highest risk, with ***** cases per 100,000 population from 2017 to 2021. In comparison, the incidence rate for breast cancer among Hispanic women during this period was *** per 100,000 population. This stark contrast in incidence rates highlights the importance of understanding racial and ethnic disparities in breast cancer diagnosis and treatment. Demographic factors influence breast cancer risk While non-Hispanic white women have the highest incidence rate, other racial and ethnic groups also face substantial risks. Non-Hispanic Black women have the second-highest rate at ***** cases per 100,000, followed by American Indian/Alaska Native women at *****. These variations underscore the need for targeted prevention and screening efforts. Interestingly, breast cancer incidence rates also differ by state, with Connecticut reporting the highest rate with *** cases per 100,000 population in 2021. Molecular subtypes and age impact breast cancer incidence The distribution of breast cancer subtypes varies among racial and ethnic groups, potentially contributing to differences in incidence rates. For white women, the hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2-) subtype accounts for ** percent of cases, which is generally less aggressive and slower growing. Age also plays a significant role in breast cancer risk, with women aged 60 to 69 accounting for ****** ductal carcinoma in situ (DCIS) cases and ****** invasive breast cancer cases in 2024. These factors emphasize the complexity of breast cancer epidemiology and the need for comprehensive research and prevention strategies.

This study aims to evaluate the feasibility of applying a method of estimating the incidence of cancer to regions of the state of São Paulo, Brazil, from real data (not estimated) and retrospectively comparing the results obtained with the official estimates. A method based on mortality and on the incidence to mortality (I/M) ration was used according to sex, age, and tumor location. In the I/M numerator, new cases of cancer were used from the population records of Jaú and São Paulo from 2006-2010; in the denominator, deaths from 2006-2010 in the respective areas, extracted from the national mortality system. The estimates resulted from the multiplication of I/M by the number of cancer deaths in 2010 for each region. Population data from the 2010 Demographic Census were used to estimate incidence rates. For the adjustment by age, the world standard population was used. We calculated the relative differences between the gross incidence rates estimated in this study and the official ones. Age-adjusted cancer incidence rates were 260.9/100,000 for men and 216.6/100,000 for women. Prostate cancer was the most common in males, whereas breast cancer was most common in females. Differences between the rates of this study and the official rates were 3.3% and 1.5% for each sex. The estimated incidence was compatible with the officially presented state profile, indicating that the application of real data did not alter the morbidity profile, while it did indicate different risk magnitudes. Despite the over-representativeness of the cancer registry with greater population coverage, the selected method proved feasible to point out different patterns within the state.

ObjectiveTriple negative breast cancer (TNBC) is a more aggressive subtype resistant to conventional treatments with a poorer prognosis. This study was to update the status of TNBC and the temporal changes of its incidence rate in the US.MethodsWomen diagnosed with breast cancer during 2011–2019 were obtained from the National Program of Cancer Registries (NPCR) and Surveillance, Epidemiology and End Results (SEER) Program SEER*Stat Database which covers the entire population of the US. The TNBC incidence and its temporal trends by race, age, region (state) and disease stage were determined during the period.ResultsA total of 238,848 (or 8.8%) TNBC women were diagnosed during the study period. TNBC occurred disproportionally higher in women of Non-Hispanic Black, younger ages, with cancer at a distant stage or poorly/undifferentiated. The age adjusted incidence rate (AAIR) for TNBC in all races decreased from 14.8 per 100,000 in 2011 to 14.0 in 2019 (annual percentage change (APC) = −0.6, P = 0.024). Incidence rates of TNBC significantly decreased with APCs of −0.8 in Non-Hispanic White women, −1.3 in West and −0.7 in Northeastern regions. Women with TNBC at the age of 35–49, 50–59, and 60–69 years, and the disease at the regional stage displayed significantly decreased trends. Among state levels, Mississippi (20.6) and Louisiana (18.9) had the highest, while Utah (9.1) and Montana (9.6) had the lowest AAIRs in 2019. New Hampshire and Indiana had significant and highest decreases, while Louisiana and Arkansas had significant and largest increases in AAIR. In individual races, TNBC displayed disparities in temporal trends among age groups, regions and disease stages. Surprisingly, Non-Hispanic White and Hispanic TNBC women (0–34 years), and Non-Hispanic Black women (≥70 years) during the entire period, as well as Asian or Pacific Islander women in the South region had increased trends between 2011 and 2017.ConclusionOur study demonstrates an overall decreased trend of TNBC incidence in the past decade. Its incidence displayed disparities among races, age groups, regions and disease stages. Special attention is needed for a heavy burden in Non-Hispanic Black and increased trends in certain groups.

SEER Limited-Use cancer incidence data with associated population data. Geographic areas available are county and SEER registry. The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute collects and distributes high quality, comprehensive cancer data from a number of population-based cancer registries. Data include patient demographics, primary tumor site, morphology, stage at diagnosis, first course of treatment, and follow-up for vital status. The SEER Program is the only comprehensive source of population-based information in the United States that includes stage of cancer at the time of diagnosis and survival rates within each stage.

Rate: Number of new cases of breast cancer (per 100,000) diagnosed at the regional or distant stage among females.

Definition: Age-adjusted incidence rate of invasive breast cancer per 100,000 female population.

Data Sources:

(1) NJ State Cancer Registry, Dec 31, 2015 Analytic File, using NCI SEER*Stat ver 8.2.1 (www.seer.cancer.gov/seerstat)

(2) NJ population estimates as calculated by the NCI's SEER Program, released January 2015, http://www.seer.cancer.gov/popdata/download.html.

The incidence rate of breast cancer among women in the United States has increased since 1975, and reached a high in 2021. In 2021, the incidence rate of breast cancer among U.S. women was 144.6 per 100,000 population. This statistic shows the incidence rate of breast cancer among women in the United States from 1975 to 2021.

This dataset shows the female breast age adjusted invasive cancer incidence rates in United States in the year 2013.

In the period 2017 to 2021, the incidence rate of breast cancer among women in the United States aged 70 to 74 years was around 479 per 100,000 population. This statistic shows the incidence rate of breast cancer among women in the United States in the period 2017 to 2021, by age.

This map uses age-standardized ratios to further aid in regional comparisons. A value of 1.0 would indicate that the region rate is identical to the overall Canadian rate; a value greater than 1.0 would indicate that the rate for that region is higher than the Canadian rate; and, in turn, a ratio value less than 1.0 would indicate that the rate for the specific region is lower than the Canadian rate. Statistically low incidences of breast cancer are found in Newfoundland and Labrador, the territories, and northern areas of most provinces. Otherwise, each province has one or more pockets of significantly high breast cancer incidence. Health status refers to the state of health of a person or group, and measures causes of sickness and death. It can also include people’s assessment of their own health.